EP
Enanta Pharmaceuticals Inc
🇩🇪XSTU.9EPGermanyHealthcare
€11.00EURup +0.50 (+4.76%)ClosedEnd of day11:27 PM
Price€11.00+0.50 (+4.76%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US29251M1062
- CUSIP
- Not reported
Company
- Employees
- 120
- Headquarters
- Watertown, United States
- Website
- https://www.enanta.com
- CEO
- Dr. Jay R. Luly Ph.D.
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- -$2.17
- P/E LTM
- -6.64
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $65.26M+0.7%up year on year
- Net income
- -$63.23M+31.28%up year on year
- Gross margin
- 94.33%+0.17%up year on year
- Free cash flow
- -$36.94M+15.22%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.